EW - Medical Devices Stock Price Gain Opportunity: Edwards Lifesciences
Healthcare derived demands
Edwards Lifesciences Corporation (EW) provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Some two dozen street research analysts see next year and 5-year EW stock price growth at a rate of +12%.
This review overlays their estimates with market professionals estimates of price behaviors of a more near-term nature. Their expectations are unintentionally revealed through repeated market-making needs to facilitate volume block trades in the stock.
Those needs come about to balance institutional demands for stocks when limited supply is